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Background: In young Chinese men of the highland immigrant population, chronic mountain sickness (CMS) is a
major public health problem. The aim of this study was to measure the disease burden of CMS in this population.
Methods: We used disability-adjusted life years (DALYs) to estimate the disease burden of CMS. Disability weights
were derived using the person trade-off methodology. CMS diagnoses, symptom severity, and individual
characteristics were obtained from surveys collected in Tibet in 2009 and 2010. The DALYs of individual patients
and the DALYs/1,000 were calculated.
Results: Disability weights were obtained for 21 CMS health stages. The results of the analyses of the two surveys
were consistent with each other. At different altitudes, the CMS rates ranged from 2.1-37.4%; the individual DALYs
of patients ranged from 0.13-0.33, and the DALYs/1,000 ranged from 3.60-52.78. The age, highland service years,
blood pressure, heart rate, smoking rate, and proportion of the sample working in engineering or construction
were significantly higher in the CMS group than in the non-CMS group (p< 0.05). These variables were also
positively associated with the individual DALYs (p< 0.05). Among the symptoms, headaches caused the largest
proportion of DALYs.
Conclusion: The results show that CMS imposes a considerable burden on Chinese immigrants to Tibet.
Immigrants with characteristics such as a higher residential altitude, more advanced age, longer highland service
years, being a smoker, and working in engineering or construction were more likely to develop CMS and to
increase the disease burden. Higher blood pressure and heart rate as a result of CMS were also positively associated
with the disease burden. The authorities should pay attention to the highland disease burden and support the
development and application of DALYs studies of CMS and other highland diseases.
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Globally, more than 140 million people worldwide live
> 2500 m above sea level; of them, 80 million live in
Asia, and 35 million live in the Andean mountains [1].
Countless others travel to the mountains for work,
trade, and sport. China has the largest and highest
highland territory in the world, and there is a large im-
migrant population in this territory [2]. The immigrant
population is composed mainly of road builders,
miners, servicemen, officials, and merchants, most of
whom are adult men. The ethnicity of the population
is mostly Han (ethnic Chinese) [2,3]. Han are at a
greater disadvantage than their Tibetan counterparts
regarding adaptation to high-altitude environments
[4,5].
Despite a long acclimatization period, some immi-
grants in the highlands suffer from chronic mountain
sickness (CMS), which is also called Monge disease [6].
CMS is a hypobaric, hypoxia-related illness that presents
with polycythemia leading to cardiac failure or neuro-
logical disorders [7]. CMS seriously affects the health of
highland immigrants and often results in significant
declines in productivity and quality of life. Patients usu-
ally experience decreased exercise tolerance, loss of
memory, headache, dizziness, and fatigue [8,9]. Com-
pared with their Tibetan counterparts, Han suffer from
significantly higher rates of CMS when they reside in
highland areas [1,10,11].
However, the decline in health status induced by
CMS in the immigrant population has been underesti-
mated in the past. The authorities focus on acute
mountain sickness because it can cause obvious loss
of manpower in some emergency situations. By con-
trast, CMS, of which the symptoms are generally not
severe, tends to be ignored by the authorities. They
believe that CMS does not affect day-time work very
much, and it can be overcome by will power and
courage derived from military discipline and patriot-
ism. However, the disease not only gradually reduces
the state of health and quality of life of individuals,
but it also decreases the working capacity of the
whole population. In the health service system for
Chinese highland troops, CMS has not been consid-
ered to be an occupational disease or to warrant
compensation. Currently, the highland troops only cal-
culate the prevalence of CMS. Quality of life is not
considered to be important by the authorities, and
the reduction in health cannot be quantitated. Conse-
quently, health service plans and occupational com-
pensation for CMS cannot be assessed at the
population level by calculating CMS prevalence alone.
The health-related quality of life of different popula-
tions may be unequal because the severity of CMS
has not been considered. Even when the CMSseverity is the same, old and young patients differ in
the extent to which they experience a loss of prod-
uctivity. At the individual level, although a scoring
system may reveal the severity of CMS, it fails to
quantitatively evaluate the health life years of which a
patient is deprived by CMS; the cumulative damage
of CMS to a person’s health cannot be determined.
Consequently, health services and prevention strategies
cannot be conducted effectively, and working stan-
dards and disability compensation cannot be set ra-
tionally. Therefore, it is necessary to evaluate the
disease burden of CMS to improve such policies.
Disability-adjusted life years (DALYs) have been
employed to quantify the burden of diseases, taking
into account healthy years of life lost due to prema-
ture death, as well as ill-health [12]. The concept of
DALYs was developed as a measurement unit to
quantify burden of disease (BOD) and injury to
human populations for the global burden of disease
(GBD) study in the early 1990s [13,14]. Since then,
DALYs have been widely used globally to estimate the
BOD at the national, international, and regional levels
[15]. The DALYs approach represents a major step in
quantifying the global and regional effects of diseases
on population health, and it provides insights for
organizations and individuals who are committed to
health policy [16]. The concept of BOD can provide
important insights for high-altitude medical research.
However, until now, little attention has been paid to
the BOD of high-altitude populations. Accordingly,
this study aimed to establish the disability weights
(DWs) of CMS and to estimate the burden of CMS
among young Chinese men in Tibet.
Methods
Ethics statement
This study was approved by the Ethics Review Board of
the Third Military Medical University, Chongqing,
China. There was no health intervention involving the
subjects. All the individual data were anonymized prior
to retrieval and analysis. Prior to commencement of the
study, all the subjects were fully informed and signed an
informed consent document.
Selection of population groups
The areas surrounding Qinghai-Tibet Road (1,138 km)
and Xinjiang-Tibet Road (1,530 km) were selected as
the study areas. These roads are both stem roads in
Tibet, and most military units in the area have condi-
tions that are considered to be representative. Every
year, the Highland Medical Corps conducts compul-
sory, routine health surveys of their troops to deter-
mine the condition of the servicemen’s health. From
April to June 2009 and from April to June 2010, we
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We randomly selected 41 units (one fourth of the
units completing routine health surveys) for this study.
The altitudes of these units ranged from 3,570-5,380
m, with an average of 4,350.9 m (standard deviation,
SD= 424.2). We classified these altitudes into four
groups: 3,500-3,999 m (8 units), 4,000-4,499 m (15
units), 4,500-4,999 m (14 units), and 5,000-5,400 m (3
units). The 2009 and 2010 surveys were conducted in
the same area and with the same units.
Data collection
During data collection, we accompanied the Medical
Corps and visited the sample units. The subject selection
criteria included the following: 1) ethnic Han; 2) having
resided in the highland for more than six months; 3)
coming from a low-altitude province (< 2,500 m); 4)
without a current, acute infection; 5) without any
chronic pulmonary diseases or any other severe chronic
diseases (e.g. skin diseases, oral diseases, digestive dis-
eases, musculoskeletal disorders, and soft tissue injury).
In each sample unit, the Medical Corps first per-
formed their routine survey in each unit’s clinic room,
which included a physical examination, behavioral
questions, and a blood draw (from an arm vein). We
extracted information about height (in meters), weight
(in kilograms), blood pressure (BP, in mmHg), heart
rate (HR, in beats/min), and current smoking and
drinking behavior (current Yes or No) from the routine
survey. We also extracted the patient’s age (in years),
highland service years (HSYs), educational level (classi-
fied as ≤ elementary school, high school, or ≥ college),
and occupation (classified as regular infantry, engineer-
ing or construction, or support) from the units’ staff
records.
Accompanying the routine examination, we obtained
each patient’s oxygen saturation (SaO2) and hemoglobin
concentration (Hb). The SaO2 was tested using a pulse
oximeter (GE Datex-Ohmeda TuffSat, USA) on the index
finger. Hb was measured using the cyanmethemoglobin
technique (Hb assay kit, MAKER, Sichuan, China; Hb
1002 analyzer, Shanghai Scientific Instrument Corpor-
ation, Shanghai, China).
The CMS diagnostic criteria included excessive
hypercythemia (Hb ≥ 210 g/L) and low oxygen satur-
ation (SaO2< 85%) [17,18]. Subjects who were diag-
nosed with CMS completed a symptom questionnaire.
The CMS symptom questionnaire was based on the
Qinghai CMS Questionnaire [18], which includes ques-
tions about seven main CMS symptoms (breathlessness
and/or palpitations, sleep disturbances, cyanosis, dilata-
tion of veins, paresthesia, headache, and tinnitus). The
participants were asked to rate each symptom accord-
ing to three severity levels (mild, moderate, and severe)during the past month. During the questionnaire, they
were not informed of the diagnosis. After the comple-
tion of the questionnaire, all the CMS subjects’ answers
were thoroughly reviewed to check for missing
values. All missing values were completed before the
observers left the unit.
Subjects who were not diagnosed with CMS did not
undergo any further testing; however, we randomly
selected a group of non-CMS subjects that was twice the
size of the CMS group to be a control group for each
unit’s data in the data analysis. Any non-CMS subjects
with missing values were excluded from the study, and
the data were complemented by another non-CMS sub-
ject in the same unit.
Disability weights for CMS
Disability weight (DW) is a key component of BOD ana-
lysis that represents the severity of an illness. DW ranges
from 0 to 1, where 0 represents healthy life and 1 repre-
sents death [19]. The GBD study group derived a series
of DWs for different health states that are the outcomes
of different diseases [20]. However, no DW is available
for a number of health states, including CMS. There are
also no DWs of other diseases that are comparable to
the health states associated with CMS in the 2004 report
of the GBD study group [20]. Because of the non-avail-
ability of DWs for CMS, we tried to establish our own
DWs for CMS health states by using the Qinghai CMS
Questionnaire symptom categories. There were seven
symptoms, and each symptom included 3 levels of sever-
ity (mild, moderate, and severe), thus representing 21
CMS health states.
We convened a nine-expert panel composed of 3
physiologists, 2 epidemiologists, 3 public health experts,
and 1 highland medical officer. To create the DWs, the
panel members performed the Person Trade-Off (PTO)
exercise using a Delphi process [21]. In the beginning,
they were asked to decide how many people with a
given CMS health state would need to be returned to
perfect health for one year to provide the same social
benefit as 1,000 healthy people living for one year
(PTO value). During the first round, each expert pro-
vided PTO values for each of the 21 CMS health
states. The panel then met as a group and discussed
each CMS health state in turn. At the start of the dis-
cussion, all the panelists received the first round’s PTO
values, provided anonymously by each of the panelists.
The group discussed the most appropriate PTO value
for each CMS state. During the discussion all opinions
were respected. When distinctive thematic considera-
tions were no longer elicited, each panelist was asked
to independently and confidentially reassign a PTO
value to each CMS state. The coefficient of variation
(CV) was calculated to determine the need for
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values. After 4 rounds, a consensus was achieved (CV
< 0.5). In all, 5 items required only 1 round, 12 items
required 2 rounds, and 4 items required 3 rounds, at
which point the Delphi process ended. The PTO values
were converted to DWs with 95% confidence intervals
(95% CI).
To describe the health states, this study used a standar-
dized, eleven-dimension description (pain or discomfort,
physical functioning, fatigue, memory and thinking, social
relationships, anxiety, speech, hearing, vision, and theuse of
hands and fingers) of the associated functional health states
for each disease stage [22,23]. Each dimension had three
levels: no problems, some problems, and severe problems.
ThehealthstatesweredescribedonanA4-sizedvignettethat
contained disease-specific information in simple termin-
ology. As a reference framework during this task, the panel
members were provided with a WHO-GBD framework
table, which displayed 7 disability classes and 22 anchoring
exampleconditions[24].Calculation of DALYs for CMS
DALYs were used to estimate the disease burden due
to CMS among young male immigrants. The DALYs
for a disease or health condition are calculated as the
sum of the year of life lost (YLL) due to premature
mortality in the population and the equivalent ‘healthy’
year lost due to disability (YLD) for incident cases of
the health condition [25]. However, people with CMS
normally do not die directly from the disease, especially
in a young population, nor was mortality due to CMS
reported during the 2009–2010 CMS epidemics in the
region. Therefore, the DALY due to CMS were equal
to the YLD.
Disease stages were evaluated by assuming a dur-
ation of 1 year, except for those with only a brief
duration and those followed by a full recovery [26].
Given that CMS is a non-communicable chronic dis-
ease; in most cases, remission appears when the pa-
tient is returned to a lower area, accordingly, we
assumed that the duration of one subject’s CMS
symptoms was an entire year and that the severity of
the CMS symptoms was averaged across the year. We
obtained the symptoms of each patient with CMS
during a cross-sectional investigation performed each
year, and used the time-section-symptoms to represent
the patients’ symptoms for the whole year. A patient’s
individual DALYs were calculated case-by-case using
the following formula [27]:YLDs r;K ; β½  ¼ D KCe
ra
r þ βð Þ2 e
 rþβð Þ Lþað Þ  r þ βð Þ Lþ að Þ½
hIn this formula, D is DW, K is an age weighting factor,
C is a constant, r is the discount rate, a is age at begin-
ning, β is a parameter from the age weighting function,
and L is life time with disability. We used the base case
recommended by Murray and Lopez, with C= 0.1658,
r= 0.03, K= 1, and β= 0.04 [28]. As far as comorbidity
was concerned, if a person had more than one CMS
symptom, a multiplicative adjustment method was
adopted to calculate the DW of the comorbidity [29].
The adjustment formula is:




Where W(d) is the total DW of an individual with mul-
tiple (d) symptoms, and wd is the DW of each health
state. For example, if one person complained of both
“poor night’s sleep” (DW=0.113) and “palpitations”
(DW=0.129), his total DW would be calculated as 1–
(1–0.113) × (1–0.129) = 0.227.
To estimate the differences in disease burden of CMS
in different groups (e.g., groups at different altitudes), we
calculated the average disease burden in each group as
the DALYs per 1,000 people (DALYs/1,000).
Statistical analysis
To control for potential changes in CMS status across
the two years of the study, the two data subsets were
analyzed separately.
Descriptive statistics were calculated for the age, body
mass index (BMI, weight in kg/height in m2), HSYs, sys-
tolic blood pressure (SBP), diastolic blood pressure
(DBP), HR, SaO2, Hb, smoking, drinking, and occupation
of the CMS and non-CMS subjects. The CMS preva-
lence, individual DALYs, and DALYs/1,000 in each
altitude group were computed. The proportions of dis-
ease burden caused by each symptom in each year in the
entire sample population were also computed. Differ-
ences between the means were tested by an analysis of
variance (ANOVA), and differences in rates or propor-
tions were tested with a chi-squared test.
To test the relationship between the individual DALYs
and the individual variables of age, BMI, HSYs, SBP,
DBP, HR, smoking, drinking, and occupation, separate
linear regression analyses were performed using the indi-
vidual DALYs as dependent variables and each individ-
ual-level variable as the independent variable, while
controlling for altitude. Variables that were significant
in each of the separate regressions were entered into a






Table 1 Disability weights for the 21 health states from the 7 symptom categories of chronic mountain sickness
Symptom categories Health stages DWs 95% CI CV
Lower Upper
Breathlessness/palpitations Mild breathlessness/palpitations 0.049 0.044 0.053 0.15
Moderate breathlessness/palpitations 0.091 0.086 0.096 0.09
Severe breathlessness/palpitations 0.129 0.120 0.139 0.11
Sleep disturbances Did not sleep as well as usual 0.043 0.040 0.046 0.09
Woke many times; poor night’s sleep 0.113 0.108 0.117 0.06
Could not sleep at all 0.218 0.207 0.229 0.08
Cyanosis Mild cyanosis 0.006 0.005 0.007 0.36
Moderate cyanosis 0.016 0.013 0.020 0.33
Severe cyanosis 0.040 0.035 0.046 0.19
Dilatation of veins Mild dilatation of veins 0.009 0.007 0.011 0.32
Moderate dilatation of veins 0.021 0.015 0.027 0.42
Severe dilatation of veins 0.044 0.036 0.052 0.28
Paresthesia Mild paresthesia 0.014 0.012 0.017 0.27
Moderate paresthesia 0.042 0.039 0.044 0.10
Severe paresthesia 0.083 0.078 0.089 0.11
Headache Mild headache symptoms 0.077 0.071 0.083 0.12
Moderate headache 0.131 0.127 0.136 0.05
Severe, incapacitating headache 0.231 0.224 0.238 0.05
Tinnitus Mild tinnitus 0.014 0.012 0.017 0.27
Moderate tinnitus 0.049 0.045 0.052 0.11
Severe tinnitus 0.095 0.092 0.099 0.06
DWs: disability weights; CV: coefficient of variation; 95% CI: 95% confidence interval.
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cause Hb and SaO2 are diagnostic factors, they were not
entered in regression analysis to avoid a vicious circle.
The standardized regression coefficients (β) with 95% CI
and the p-values from the analyses are reported.
Before all tests, the normality and homogeneity of
variance were tested for each continuous variable. A
log transformation was used for variables with non-
normality or non-homogeneity of variance. In all the
analyses, a p-value <0.05 was considered to be statisti-
cally significant. SPSS 13.0 software was used (Chicago,
IL, USA).Results
Disability weights of CMS
After three rounds of the Delphi process, the panel
reached a consensus with a CV< 0.5. In this way, the
DWs of 21 CMS health stages were obtained. Severe
headache received the highest weight of 0.231, while
mild cyanosis received the lowest weight of 0.006, as
shown in Table 1. The fourth and fifth columns in the
table show the upper and lower 95% CI of the DWs, and
the sixth column shows the CVs from when the panel
achieved a consensus.Variables between CMS and non-CMS
The descriptive statistics for each continuous, individual
variable in the CMS and non-CMS groups are shown by
year in Table 2. The population of sample units differed
little between the two years. In 2009, the total sample
Han population was 2,277; the population of each unit
ranged from 23 to 139 individuals, with an average of
55.5 (SD= 24.1). In 2010, the total sample population
was 2,155; the population of each unit ranged from 21 to
150 individuals, with an average of 52.6 (SD= 25.5).
Compared with the non-CMS group, the CMS group
was significantly older (2009: p< 0.001; 2010: p= 0.004),
had more HSYs (2009: p< 0.001; 2010: p= 0.010), and
had a higher SBP (2009: p< 0.001; 2010: p< 0.001), DBP
(2009: p= 0.002; 2010: p< 0.001), and HR (2009: p
< 0.001; 2010: p< 0.001). BMI was not found to be sig-
nificant (2009: p= 0.131; 2010: p= 0.641).
The descriptive statistics for each categorical variable
in the CMS and non-CMS groups are presented by year
in Table 3. The CMS group had a higher proportion of
smokers and engineering or construction (E&C) workers.
In the CMS group, 61.99-62.54% were smokers and
35.24-39.88% were E&C workers, compared with the
non-CMS group, in which 47.94-54.67% were smokers
and 18.85-21.59% were E&C workers. Neither
Table 2 Means and standard deviations of each
continuous individual variable in CMS and non-CMS




CMS 23.45 (3.73)* 23.31 (3.57)*
Non-CMS 22.51 (2.95) 22.61 (3.46)
Body mass index (kg/m2)
CMS 21.69 (2.56) 21.56 (2.78)
Non-CMS 21.42 (2.65) 21.48 (2.51)
Highland service years
CMS 4.24 (3.33)* 4.10 (3.24)*
Non-CMS 3.44 (2.66) 3.53 (2.98)
Systolic blood pressure (mmHg)
CMS 120.98 (11.47)* 121.77 (10.74)*
Non-CMS 116.96 (10.27) 118.41 (9.45)
Diastolic blood pressure (mmHg)
CMS 77.31 (11.32)* 78.30 (12.67)*
Non-CMS 75.07 (7.65) 73.80 (7.78)
Heart rate (beat/min)
CMS 81.17 (10.74)* 80.06 (8.53)*
Non-CMS 76.63 (8.13) 77.07 (8.02)
Hemoglobin (g/L)
CMS 216.68 (5.62)* 216.10 (5.74)*
Non-CMS 191.05 (12.69) 190.94 (13.54)
Oxygen saturation (%)
CMS 82.45 (2.69)* 81.69 (2.41)*
Non-CMS 88.85 (3.43) 89.01 (3.50)
SD: standard deviation; CMS: chronic mountain sickness.
*: p< 0.05 vs. control based on ANOVA; †: CMS n= 321, non-CMS n= 642; {:
CMS n= 315, non-CMS n= 630.
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dents in each group who drank was found to be signifi-
cant. Finally, there was no significant difference between
the regular infantry and the support categories in the
rate of CMS (2009: χ2 = 1.013, p= 0.314; 2010: χ2 = 0.645,
p= 0.422).
CMS prevalence and estimates of DALYs
The numbers of CMS patients, prevalence, average indi-
vidual DALYs, and DALYs/1,000 in the different altitude
groups are presented in Table 4. There were 321 and
315 patients in the sample populations reported in the
2009 and 2010 surveys, respectively. In 2009, the preva-
lence ranged from 2.1-37.4%, with an average of 14.1% in
the different altitude groups. In 2010, the prevalence ran-
ged from 3.2-33.6%, with an average of 14.8%. Using the
chi-squared test, the CMS rate was found to be signifi-
cantly higher in the higher altitude groups (2009:
χ2 = 59.564, p< 0.001; 2010: χ2 = 108.306, p< 0.001).There were no significant differences in prevalence in
different years within the same altitude group (p> 0.05).
In 2009, the average individual (CMS patient) DALYs
ranged from 0.13-0.33 in the various altitude groups,
with an average of 0.25 (SD= 0.12). In 2010, the DALYs
ranged from 0.17-0.30, with an average of 0.25 (SD=
0.11). In 2009, the DALYs/1,000 (entire population) ran-
ged from 3.60-52.24 in the various altitude groups, with
an average of 35.54 (SD= 15.37). In 2010, it ranged from
4.01-52.78, with an average of 37.09 (SD= 16.96). The
one-way ANOVA found that both the individual DALYs
(2009: F= 7.251, p< 0.001; 2010: F= 13.979, p< 0.001)
and the DALYs/1,000 (2009: F= 151.547, p< 0.001; 2010:
F= 154.286, p< 0.001) were significantly higher in the
higher altitude groups. We also found that neither the
individual DALYs nor the DALYs/1,000 were significantly
different between the two years at the same altitude
(p> 0.05).
The proportion of the disease burden caused by the 7
CMS symptoms in the entire sample population is pre-
sented in Table 5. In the two annual surveys, the propor-
tions of the disease burden caused by each symptom
were similar; the disease burden caused by headaches
made up the largest proportion in the population (33.5%
in 2009 and 32.2% in 2010), whereas breathlessness/pal-
pitations and sleep disturbances made up the second-
and third-largest proportions, respectively.
Higher age, HSYs, SBP, DBP, and HR were found to be
significantly and positively associated with the individual
DALYs in the separate linear regression analyses
(Table 6). Smoking and working in E&C occupations
were both significantly and positively associated with in-
dividual DALYs. In the 2009 data, a support occupation
was found to have a significant and negative association
with individual DALYs compared with the regular infan-
try; however, there was no significant association in the
2010 data. BMI, drinking, and education were not found
to be significant. Because age and HSYs were highly cor-
related (2009: r= 0.978, p< 0.001; 2009: r= 0.971, p
< 0.001), age was excluded from the multiple model to
avoid multicollinearity. When the significant variables
were put into the multiple model, SBP and support occu-
pation lost significance, while HR retained significance
only in the 2009 data (Table 7).
Discussion
As a burden of disease specific to a particular region, this
study focused on CMS in the highland immigrant popula-
tion. To our knowledge, this work is the first to introduce
the concept of DALYs to highland medicine. In this study,
we established the local DWs for CMS according to seven
main symptoms, which have not been considered in previ-
ous global or regional BOD studies. This study is also the
first to estimate the burden of CMS among the young
Table 3 Statistics for each categorical individual variable by CMS and non-CMS groups in 2009 and 2010
Variable 2009 2010
CMS Non-CMS p* CMS Non-CMS p*
Smoking
No 122 291 0.030 118 328 <0.001
Yes 199 351 197 302
Drinking
No 287 555 0.191 277 547 0.630
Yes 34 87 38 83
Education
≤Junior school 132 268 0.261 145 260 0.338
High school 173 325 142 315
≥College 16 49 28 55
Occupation
Regular infantry 117 294 <0.001 124 284 <0.001
Engineering and construction 128 121 111 136
Support 76 227 80 210
Total 321 642 315 630
*: p-value based on chi-squared test.
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based on the data from two recent annual surveys.
Most BOD studies use the selection of diseases states
from the International Classification of Disease, Injuries,
and Causes of Death, Tenth Revision (ICD-10) [30-32].
In the ICD-10, CMS (namely, secondary polycythemia
due to high altitude) is coded D75.1 [33], but there are
no further subdivided consequence categories. Consider-
ing the multiple symptoms characteristic of CMS, we
did not merely establish a single DW for CMS because
this illness is not characterized by a single health prob-
lem. In addition, it is difficult to accurately measure the
DALYs with a single DW because the condition has a
variable presentation that includes several different
symptoms, each with its own severity level. Thus, we
derived DWs for the detailed CMS symptoms and 21
potential health states that can result from those symp-
toms at varying degrees of severity. This division made
the DWs more detailed and easier to handle. The calcu-
lation of the DWs in this study was based on the PTO
methodology and used a panel approach to elicitTable 4 Annual CMS patient numbers, prevalence, average in
in 2009 and 2010
Altitude 2009
N* n (%)** DALY† DALY/1
3,500-3,999 m 569 12 (2.1) 0.13 (0.11) 3.60 (2.2
4,000-4,499 m 889 123 (13.8) 0.24 (0.13) 31.80 (1
4,500-4,999 m 687 137 (19.9) 0.26 (0.11) 52.24 (1
5,000-5,400 m 131 49 (37.4) 0.33 (0.08) 112.21
*: total number in each altitude group; **: number of patients (with prevalence in %
deviation in brackets); {: DALYs per 1,000 of each altitude group (with the standardvaluations of the different CMS health states. The panel
included representatives from four types of specialties,
which may reflect different specialties.
In this study, the overall disease burden caused by
CMS among the young male Chinese immigrant popula-
tion was 35.54-37.09 DALYs/1,000 in the sample region.
Although there are no comparable DALYs data specific
to CMS from previous studies, we compared our data
with other non-communicable diseases as a reference.
According to the WHO disease and injury regional esti-
mates for 2004 [34], the DALYs/1,000 due to CMS in
our study were lower than those attributable to neuro-
psychiatric conditions in China’s 15- to 44-year-old male
population, which caused 40.66 DALYs/1,000. However,
the CMS DALYs/1,000 were higher than those for any
other type of non-communicable condition. Unfortu-
nately, a comparison between this work and the GBD
study of non-communicable conditions is only partly
possible because of differences in the data collection
strategies and in the populations studied. The sample in
the present study did not represent an entire nation ordividual DALYs, and DALYs/1,000 in each altitude group
2010
,000{ N* n (%)** DALY† DALY/1,000{
6) 534 17 (3.2) 0.17 (0.11) 4.01 (3.49)
6.62) 896 133 (14.8) 0.23 (0.12) 35.71 (19.20)
7.88) 603 124 (20.6) 0.26 (0.09) 52.78 (22.94)
(40.33) 122 41 (33.6) 0.30 (0.11) 110.67 (28.20)
); †: average individual DALYs of each altitude group (with the standard
deviation in brackets).
Table 5 Each CMS-symptom-caused DALYs/1,000 and its proportion in the entire sample population in 2009 and 2010
Symptoms 2009 2010
DALYs/1,000† Proportion (%){ DALYs/1,000† Proportion (%){
Breathlessness/palpitations 8.55 21.5 8.88 21.4
Sleep disturbances 8.71 21.9 10.71 25.8
Cyanosis 1.23 3.1 1.03 2.5
Dilatation of veins 1.47 3.7 1.57 3.8
Paresthesia 3.21 8.1 2.77 6.7
Headache 13.31 33.5 13.40 32.2
Tinnitus 3.29 8.3 3.20 7.7
†: The DALYs/1,000 for each symptom were calculated by the sum of the DALYs due to each symptom divided by the total sample population; {: The proportion
of each symptom was calculated by the sum of the DALYs due to each symptom divided by the sum of DALYs.
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http://www.biomedcentral.com/1471-2458/12/401region, but rather was a specific immigrant population
with high susceptibility to CMS. Nevertheless, the bur-
den of CMS in the immigrant population may be consid-
ered to be high because approximately 3 months of
healthy life is lost per CMS patient. This loss equates to
approximately 2 weeks per immigrant when considered
in relation to the population as a whole.
In previous reports, CMS has been found to affect 5-
15% of the population at and above 3,200 m in Andean
countries [35]. In a 4,300-m area in Peru, the prevalence
was 6.8-15.4% in a miner population between the ages ofTable 6 Separate linear regression analyses of the relationshi
controlling for altitude
Variable 2009 (n = 321)
β 95% CI
Age 0.169 (0.061, 0.277)
Body mass index 0.042 (−0.067, 0.151)
Highland service years 0.177 (0.069, 0.285)
Systolic blood pressure 0.139 (0.033, 0.245)
Diastolic blood pressure 0.284 (0.180, 0.388)
Heart rate 0.147 (0.040, 0.253)
Smoking
No (ref.) 0.000
Yes 0.173 (0.068, 0.278)
Drinking
No (ref.) 0.000
Yes −0.014 (−0.121, 0.093)
Education
≤Elementary school(ref.) 0.000
High school −0.029 (−0.140, 0.081)
≥College 0.047 (−0.064, 0.157)
Occupation
Regular infantry (ref.) 0.000
Engineering and construction 0.162 (0.051, 0.273)
Support −0.125 (−0.237, -0.014)
ref.: reference; β: regression coefficient of each variable or category; 95% CI: 95% co20 and 39. In Tibet, an overall prevalence of 5.6% in im-
migrant civilians was reported; in Lhasa immigrant civi-
lians, the CMS rate was 2.2-8.7% [17]. However, despite
some differences in diagnostic criteria, the results of the
different studies are partially comparable because of the
variance in environment, population characteristics, and
geographical factors. In a similar young soldier popula-
tion in Tibet, the CMS prevalence was reported to range
from 9.3% (in Lhasa at 3,650 m) to 30.4% (in an area at
5,000 m) [36], which is similar to our findings (2.1-
37.4%), although, our figures were lower for lower-p between individual DALYs and individual variables after
2010 (n = 315)
p β 95% CI p
0.002 0.167 (0.062, 0.272) 0.002
0.447 0.055 (−0.052, 0.163) 0.313
0.001 0.157 (0.051, 0.262) 0.004
0.010 0.120 (0.015, 0.226) 0.026
<0.001 0.214 (0.107, 0.321) <0.001
0.007 0.152 (0.046, 0.258) 0.005
0.000
0.001 0.143 (0.038, 0.247) 0.008
0.000
0.794 0.037 (−0.069, 0.143) 0.490
0.000
0.605 −0.101 (−0.211, 0.008) 0.069
0.406 0.053 (−0.056, 0.163) 0.340
0.000
0.004 0.159 (0.050, 0.267) 0.004
0.028 −0.108 (−0.218, 0.001) 0.052
nfidence interval of each β; p: p-value of each β.
Table 7 Multiple linear regression analyses of the relationship between individual DALYs and individual variables after
controlling for altitude
Variable 2009 (n = 321) 2010 (n = 315)
β 95% CI p β 95% CI p
Altitude 0.254 (0.147, 0.360) <0.001 0.204 (0.098, 0.310) <0.001
Highland service years 0.148 (0.045, 0.251) 0.005 0.135 (0.031, 0.239) 0.011
Systolic blood pressure −0.021 (−0.139, 0.098) 0.732 −0.048 (−0.170, 0.074) 0.438
Diastolic blood pressure 0.183 (0.061, 0.304) 0.003 0.257 (0.137, 0.376) <0.001
Heart rate 0.120 (0.014, 0.225) 0.026 0.085 (−0.023, 0.193) 0.124
Smoking
No (ref.) 0.000 0.000
Yes 0.113 (0.010, 0.216) 0.031 0.136 (0.035, 0.236) 0.008
Occupation
Regular infantry (ref.) 0.000 0.000
Engineering and construction 0.143 (0.030, 0.257) 0.013 0.150 (0.036, 0.264) 0.010
Support 0.091 (−0.022, 0.205) 0.114 0.077 (−0.036, 0.191) 0.181
ref.: reference; β: regression coefficient of each variable or category; 95% CI: 95% confidence interval of each β; p: p-value of each β.
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3.2%). The main reason for this discrepancy may be that
their criteria were slightly lower (Hb> 200 g/L and SaO2
< 85%). In another report from Peru, in which the cri-
teria were Hb> 213 g/L and SaO2< 83%, a male popula-
tion living at 4,300 m had a CMS prevalence of 15.6%
[37], which is similar to our findings (4,000-4,499 m:
13.8-14.8%).
In this study, the prevalence of CMS significantly
increased with ascent. When the altitude increased from
approximately 3,500 m to 5,500 m, the prevalence
increased approximately ten fold. Similarly, both the in-
dividual DALYs and the DALYs/1,000 also increased sig-
nificantly with altitude. This result indicates that higher
altitude not only increases the prevalence of CMS but
also contributes to an aggravated CMS disease burden.
For example, in the 3,500-3,999 m area for the total im-
migrant population, every immigrant lost nearly one-
and-a-half days of healthy life annually because of CMS.
In contrast, in the 5,000-5,400 m area, they lost one-and-
a-half months of healthy life each year. When consider-
ing only the CMS patient, in the 3,500-3,999 m area,
every CMS patient lost nearly two months of healthy life
annually; in the 5,000-5,400-m area, they lost nearly
three-and-a-half months of healthy life annually.
The statistical analyses indicated that some factors, in-
cluding age, HSYs, BP, HR, smoking, and occupation, not
only significantly differed between the CMS and non-
CMS groups but also associated with the individual dis-
ease burden in the CMS population. The CMS popula-
tion had a higher age, HSYs, BP, HR, smoking rate, and
proportion of E&C occupations. These factors will now
be discussed in relation to previous studies.
The study from Peru suggested that CMS is a clinical
manifestation of aging at high altitudes in nativehighlands [38]. Other studies have also reported that
high-altitude dwellers show earlier cardiovascular degen-
erative changes with aging [39,40]. The results of the
present study indicate that the CMS group was older
than the non-CMS group and had a longer highland ser-
vice history. Age and HSYs were also positively asso-
ciated with the individual DALYs of the CMS patients. In
the sample population, the men always joined the army
at the ages of 17–19 and were sent to the highland for
service after 0.5 to 1 year of training; therefore, subjects
of the same age had similar highland service years. Thus,
the effects of age and HSYs cannot be discussed inde-
pendently because both variables represent aging in the
highland. Aging in the highland causes not only a greater
number of CMS patients but also a heavier CMS disease
burden, i.e., prolonged time spent in the highland could
cause a healthy person to develop CMS [17] and could
aggravate the severity of CMS symptoms [7]. Thus, rede-
ploying soldiers seriously affected by CMS to a lower-
altitude service area would help to decrease the health
lost for the highland service population.
A previous study found that subjects with CMS showed
reductions in the response to the stimulation of the per-
ipheral chemoreflexes and in baroreflex control of heart
rate and blood pressure, which correlated with increases in
CMS scores and in hemoglobin levels [41]. It is also
known that vasodilator action of hypoxia at the microca-
pillary level may be incapable of decreasing systemic
hypertension [42]. In this study, we found that, compared
with the non-CMS group, members of the CMS group
had higher BP (both SBP and DBP) and HR; this result is
consistent with the findings of other reports [43-45]. We
also found that BP (especially DBP) and HR were also sig-
nificantly positively associated with individual DALYs in
CMS patients. This result implies a progressive
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http://www.biomedcentral.com/1471-2458/12/401impairment of cardiovascular regulation among the CMS
patients. Accordingly, improving cardiovascular regulation
may help to alleviate the disease burden of CMS.
As some scholars have suggested, smoking is a risk fac-
tor for altitude disease [9,46]. Previous research in the
male Han population has suggested that the prevalence
of CMS is three times higher in smokers than in non-
smokers [9]. In the present study, the CMS group had a
higher smoking rate than the non-CMS group. More-
over, smoking was also associated with higher individual
DALYs in the CMS patients. The mechanism causing
this effect could be that cigarette smoking worsens hyp-
oxia, produces a lower oxygen-carrying capacity, causes
centrilobular emphysema, reduces alveolar ventilation,
and thus impairs cardiopulmonary function. Accordingly,
smoking control among the highland immigrant popula-
tion would decrease both the prevalence and the disease
burden of CMS; the authorities should consider this
possibility.
Patients with E&C occupations were more likely to de-
velop CMS and had heavier disease burdens. The possible
reason for this result is that these occupations are asso-
ciated with a relatively heavy physical burden. Physical ex-
ertion leads to greater oxygen consumption, which
aggravates hypoxia [47,48]. These occupations may also be
more likely to bring people into contact with dust, waste
gas, and cold weather, which potentially increase the risk
of CMS. Thus, immigrants with E&C occupations in the
highland should have more protection for CMS prevention
and more compensation for health damages.
Regarding symptom categories, the greatest BOD due
to CMS is associated with headaches, sleep disturbances,
and breathlessness/palpitations, which made up almost
three fourths of the total BOD. The high contribution of
these symptoms to BOD is due to both their high preva-
lence and their high DW. These three symptoms may
play an important role in the course of CMS, and they
should be considered in measures to improve the quality
of life for immigrant highlanders.
Strengths and limitations
There are several strengths of this study. First, the valid-
ity of the CMS data obtained from the military medical
surveys is likely to be high. The data were collected by
trained investigators using consistent criteria; the investi-
gators were able to adequately assess the young men’s
health status in the vast majority of the cases. Second,
this study improves on some earlier studies in which the
comorbidity of DWs for different health states was deter-
mined by simple addition; this procedure leads to the
DW exceeding 1 at the individual level. Comorbidity was
handled in the DW and DALYs calculations in our work,
which makes the results more reliable. Third, this study
described the BOD based on data from recent years;therefore, the DALYs may represent the actual disease
burden in the population. We attempted to improve the
DALYs measure’s sensitivity by comparing two sequential
years; the results of the two data sets revealed no signifi-
cant differences. A further strength of this study is that
the authors have made modest and sensible health im-
provement recommendations relating to the specific
symptoms that were identified as problematic, thus
avoiding the criticism made of many studies of this gen-
eral type that, for a variety of reasons, the measures used
are not suitable for use as a basis for resource allocation
decisions [49].
However, the results of this study should be inter-
preted with caution for the following reasons.
First, in the study of DW, cultural differences may
affect the determination of PTO values, and different
cultural backgrounds might account for variations in the
DW ratings. Because of the relative localization of the
expert panel, the DWs derived from this study are lim-
ited and should be considered regional DWs. However,
because our primary aim was to focus on Tibet and be-
cause most highland immigrants reside in this territory,
the cultural difference problem may not have a great im-
pact on this study.
Second, The PTO method has been questioned for
having a lower test-retest reliability than the time-trade-
off technique, which is another common technique used
in DALYs studies [50]; however, this may be less of a
problem when using the Delphi method.
Third, a case-based approach may cause a substantial
increase in the amount of data required, whereas an inte-
grated health registration system has not been used for
the entire immigrant population; therefore, the authors
selected a population of young servicemen as a sample.
Consequently, the data were collected from a specialized
male population in which age, diet, and behaviors were
similar; this specialized population may limit the
generalizability of the results to other populations.
Fourth, this study handled DALYs in the same way that
we handled YLD. However, whether some people may
have died from CMS is difficult to determine. Because of
the confounding effects of other diseases and the diffi-
culty attributing each case to CMS, some potential
symptoms not listed in the Qinghai-CMS-questionnaire
may have not been considered.
Moreover, the assumption that the duration of CMS is
an entire year and the averaging of its severity over the
course of a year are not precise; some symptoms may
occur intermittently, and the severity may change over
time. Nevertheless, a disease that is chronic in nature
may not change too much on average over a year, and
the purpose of this study was to investigate the popula-
tion level, not individual level, CMS burden, therefore
this assumption was acceptable in this study.
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overall trends in BOD within a region or in a population
over time [26]. This study, however, did not analyze the
tendency of CMS to vary within an area; we investigated
the BOD only within two neighborhoods in two recent
years using a simple cross-sectional investigation. Thus,
future studies may be necessary.
Conclusion
CMS is one of the most important diseases that burdens
the highlanders. Accordingly, CMS is a public health
issue in Tibet. This study is the first step in evaluating
the BOD in the highland areas to suggest the importance
of BOD indicators when considering health compensa-
tion policies and workforce rotation strategies in the
highlands. The results show that CMS imposes a consid-
erable burden on young male highland immigrants.
Immigrants with characteristics such as higher residen-
tial altitude, more advanced age, longer HSYs smoking
behavior, and engineering or construction occupations
were more likely to develop CMS and to increase the
burden of disease. Higher BP and HR as a result of CMS
were also positively associated with the disease burden,
which implies a progressive impairment of cardiovascu-
lar regulation. Thus, the authorities should pay more at-
tention and should create reasonable strategies to
alleviate the disease burden of CMS. As a useful tool in
high-altitude public health research, further development
and application of a DALYs measure that focuses on the
full disease spectrum in the highland population
should be supported.
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